Depression and anxiety: implications for nosology, course, and treatment.
International epidemiologic and clinical studies have shown that comorbid depression and anxiety is of major importance, resulting in more severe symptoms, impairment, subjective distress, and longitudinal course than either anxiety or depression alone. Threshold and subthreshold levels of anxiety ("A," "a") and depression ("D," "d") can be defined on the basis of duration, frequency, impairment, and number of symptoms. These letters can then be used to designate the various combinations of depression and anxiety, e.g., AD, aD. Current evidence demonstrates the importance of evaluating both threshold and subthreshold levels of depression and anxiety.
Angst
J
J
Psychiatrische Universitätsklinik, Zürich, Switzerland.
D001008:Anxiety Disorders / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology; D015897:Comorbidity; D003866:Depressive Disorder / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology; D006801:Humans; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D009626:Terminology as Topic
D017367:Selective Serotonin Reuptake Inhibitors